Navigating and clarifying the healthcare journey.
It’s personal.
About us
Providing healthcare professionals with the insights needed to impact patient care.
navify® digital solutions from Roche Diagnostics are designed to transform laboratory and clinical data into actionable insights, delivering operational, financial and clinical value while helping to personalize care along the entire patient journey.
Our vision is to create a connected and agile healthcare system where digital technologies drive better care. Our mission is to deliver clinical, operational and financial value by integrating data, optimizing workflows while enabling informed decisions. By accelerating access to innovation, we provide healthcare professionals with the insights and tools needed to enable better outcomes.
Drawing on our strength in diagnostics, digital health and pharmaceuticals, Roche has set personalized healthcare at the center of our business strategy. Combining connectivity, interoperability and our commitment to cybersecurity and data privacy, navify digital portfolio gives customers the peace of mind of being able to leverage the latest innovation securely with the support of Roche’s exceptional health science expertise.
Fragmented patient data across different healthcare settings hinders the ability to generate insights. Clinicians often lack the time to sift through the latest research or compile patient diagnostic data for review. To provide personalized care, healthcare professionals need easy, decentralized access to the right data. We support this by ensuring healthcare providers have timely access to the patient data they need.
Backed by over 120 years of medical innovation, Roche develops tools that use data to support pharmaceuticals and diagnostics. We bring expertise and interoperability to healthcare systems, addressing care gaps across the patient journey. Our commitment to impacting patient care drives the development of digital solutions to enhance clinician performance.
Fritz Hoffmann-La Roche believed that science could unlock the mysteries of disease and was among the first to apply this on an industrial scale. It set Roche on a path to become one of the world's leading healthcare companies, giving millions of patients access to ground-breaking diagnostics and therapies.
Still owned by the founding family, Roche can balance the market forces that incentivise innovation with the concern for society’s long-term interests.
Since its restructuring in 2000, Roche has integrated the strengths of its diagnostics and pharmaceuticals divisions to advance personalized healthcare. Through innovations in diagnostic techniques, molecular-targeted medicines, gene sequencing and tissue diagnostics, Roche enables earlier disease detection and more precise treatments. As a leader in in vitro diagnostics, Roche is committed to delivering targeted therapies in oncology, immunology and more, enhancing patient care across conditions.